Literature DB >> 2156443

Transfer of enalaprilat across rat liver cell membranes is barrier limited.

A J Schwab1, F Barker, C A Goresky, K S Pang.   

Abstract

The liver cell entry of enalaprilat, the polar, pharmacologically active dicarboxylic acid metabolite arising from esterolysis of enalapril, a new angiotensin-converting enzyme inhibitor, was examined in the perfused rat liver by use of the multiple-indicator dilution technique. [Phenylpropyl-2,3-3H]enalaprilat was injected into the portal vein in a bolus of blood containing 51Cr-labeled red blood cells (a vascular reference) and 125I-labeled albumin and [14C]sucrose (interstitial references that do not enter cells), with observation of the time courses of their outflow into the hepatic venous blood. A quantitative evaluation of the data was carried out by use of the barrier-limited, space-distributed variable transit time model (C.A. Goresky, G.G. Bach, and B. E. Nadeau, J. Clin. Invest. 52:991-1009, 1973). For data up to 60 s after injection, the transfer coefficients for influx, efflux, and sequestration were 0.018 +/- 0.004 (means +/- SD), 0.044 +/- 0.017, and 0.033 +/- 0.007 s-1, respectively. The influx permeability surface area product (influx clearance) per gram was 0.0057 +/- 0.0013 ml.min-1.g-1, and the rapidly accessible cellular equilibrium distribution space for enalaprilat was 0.137 +/- 0.022 ml water/g wet wt. At times beyond 60 s, the fitted data deviated systematically from the experimental data, suggesting the presence of an additional intracellular pool. With this addition, the coefficients for transfer between the intracellular pools were 0.0150 +/- 0.0045 s-1 for the direction cytoplasmic pool (pool 1)----additional pool (pool 2) and 0.0234 +/- 0.0069 s-1 for the opposite direction, and the fitted volumes of pools 1 and 2 became 0.126 +/- 0.021 and 0.082 +/- 0.018 ml/g, the total accessible cellular distribution space became 0.208 +/- 0.036 ml/g wet wt, and the sequestration transfer coefficient became 0.027 +/- 0.007 s-1. The data indicate that, as previously postulated (I. A. M. de Lannoy and K. S. Pang, Drug Metab. Dispos. 14: 513-520, 1986), the enalaprilat flux across liver cell membranes is retarded by a diffusional barrier. The results also indicate that enalaprilat is excluded from part of the volume of hepatocytes, as expected for an anionic compound crossing the membrane in charged rather than protonated form, given the negative electrical potential of the cytosol vs. the extracellular space.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156443     DOI: 10.1152/ajpgi.1990.258.3.G461

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

Review 3.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

5.  Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.

Authors:  Brian C Ferslew; Kathleen Köck; Arlene S Bridges; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2014-06-23       Impact factor: 3.922

6.  Organ clearance concepts: new perspectives on old principles.

Authors:  G L Sirianni; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

7.  Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver.

Authors:  M Weiss; O Kuhlmann; D Y Hung; M S Roberts
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

8.  Photoreleasable ligands to study intracrine angiotensin II signalling.

Authors:  Artavazd Tadevosyan; Myriam Létourneau; Benjamin Folch; Nicolas Doucet; Louis R Villeneuve; Aida M Mamarbachi; Darlaine Pétrin; Terence E Hébert; Alain Fournier; David Chatenet; Bruce G Allen; Stanley Nattel
Journal:  J Physiol       Date:  2015-01-07       Impact factor: 5.182

9.  A physiological model for renal drug metabolism: enalapril esterolysis to enalaprilat in the isolated perfused rat kidney.

Authors:  I A de Lannoy; H Hirayama; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1990-12

10.  The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.

Authors:  Urban Fagerholm
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.